FIELD: pharmacology.
SUBSTANCE: invention relates to the new use of small molecules and in particular of indolyl- and indolinyl-hydroxamates, for treating a patient suffering from heart failure or destruction of nerve cells. 
.
EFFECT: increaseding the treatment efficiency.
9 cl, 9 dwg, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT FOR THE TREATMENT OF CARDIOMYOPATHY, PREVIOUS MYOCARDIAL INFARCTION AND CHRONIC HEART FAILURE | 2018 |
|
RU2795320C2 |
| APPLICATION OF DIPEPTIDYLPEPTIDASE IV INHIBITORS | 2004 |
|
RU2385723C2 |
| COMBINED DRUG PREPARATION CARDIFOL EXHIBITING CARDIOPROTECTIVE, ANTIAGGREGANT AND ANTI-ISCHEMIC ACTION ON CARDIOVASCULAR SYSTEM | 2011 |
|
RU2446806C1 |
| METHOD OF MYOCARDIUM INFARCTION TREATMENT | 2003 |
|
RU2330665C2 |
| PHARMACEUTICAL COMBINATION OF ATORVASTATIN AND NICERGOLIN FOR PREVENTING OR TREATING CEREBROVASCULAR DISEASE | 2011 |
|
RU2481124C1 |
| APPLICATION OF KAURAN COMPOUNDS FOR MEDICINES PRODUCTION | 2004 |
|
RU2345761C2 |
| APPLICATION OF BETA-HYDROXYBUTYRATE OR ITS PHARMACEUTICALLY ACCEPTABLE SALTS FOR PREPARATION OF MEDICATION WHICH POSSESSES CYTOPROTECTIVE ACTIVITY, INCLUDING NEUROPROTECTIVE, CARDIOPROTECTIVE, ANTI-ISCHEMIC, ANTI-HYPOXIC, ANTI-STRESS, ACTOPROTECTIVE AND ADAPTOGENIC ACTIVITY, MEDICATION AND METHOD OF PREVENTION, RELIEF AND TREATMENT BY MEANS OF SAID MEDICATION | 2009 |
|
RU2426535C2 |
| CELL-BASED THERAPY OF ISCHEMIC TISSUE | 2009 |
|
RU2535966C2 |
| MILD CATIONIC MITOCHONDRIAL UNCOUPLERS | 2010 |
|
RU2527519C2 |
| APPLYING MOXONIDINE FOR TREATMENT OF POST-INFARCTION STATES | 2000 |
|
RU2261097C2 |
